Key Takeaways
- The company delivered adjusted earnings per share of 64 cents, falling short of the 73-cent Wall Street forecast
- Total revenue declined 8% compared to the prior year, reaching $4.44 billion versus analyst expectations of $4.41 billion
- Organic revenue fell 3%, underperforming Nielsen’s global retail sales data by approximately 1.5 percentage points
- Full-year projections remain unchanged: organic revenue expected to decline 1.5%–2%, with adjusted earnings down 16%–20%
- Shares of GIS declined 0.8% in pre-market activity, extending a 17% loss in 2026 and more than 34% over the trailing year
General Mills delivered disappointing fiscal third-quarter results on Wednesday, with the bottom line missing Wall Street’s expectations despite revenue barely exceeding forecasts. The food giant maintained its previously lowered guidance from last month, providing little comfort to shareholders.
The company’s adjusted earnings landed at 64 cents per share, significantly trailing the analyst consensus of 73 cents. Total revenue, accounting for acquisitions and divestitures, contracted 8% from the year-ago period to reach $4.44 billion, narrowly surpassing the Street’s $4.41 billion estimate.
Looking at organic sales performance, the 3% decline highlighted continued challenges. This figure lagged Nielsen’s measured global retail sales by about 1.5 percentage points, indicating the company is losing market share rather than simply battling industry-wide pressures.
Shares retreated 0.8% in early Wednesday trading. Before this latest earnings release, the stock had already tumbled 17% year-to-date in 2026 and plunged over 34% during the past twelve months, positioning it among the weakest performers in the packaged foods sector.
Private Label Gains Ground as Budget-Conscious Shoppers Pull Back
The underlying narrative is straightforward. Cost-conscious consumers facing financial pressures are increasingly opting for private-label and retailer-branded alternatives over household names like Cheerios, Lucky Charms, and Pillsbury.
This trend has been accelerating steadily. Food manufacturers that aggressively raised prices during the inflation spike are now confronting the consequences. General Mills finds itself squarely in this predicament.
Meanwhile, consumer eating habits are evolving away from heavily processed and packaged goods. The rising popularity of GLP-1 weight-loss medications has intensified this shift, influencing shoppers toward healthier food choices.
Additional uncertainty surrounding consumer spending patterns — influenced in part by geopolitical developments including the Iran conflict — has further dampened demand for traditional pantry items.
Company Maintains Previously Reduced Annual Forecast
General Mills kept its full-year guidance intact, though this outlook had already been trimmed in the previous month. Management continues to project organic revenue will contract between 1.5% and 2% for the fiscal year.
Adjusted operating income and adjusted earnings per share are both anticipated to fall 16% to 20% on a constant currency basis. This represents a substantial decline that investors have been absorbing for several months.
The unchanged forecast did little to calm investor concerns. Between organic sales underperforming retail benchmarks and the earnings shortfall adding to an already challenging period, Wednesday’s quarterly report offered scant evidence of a turnaround.
S&P 500 futures advanced 0.4% on Wednesday, while the broader index has fallen 1.9% through 2026 to date.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
